Healthy aging has changed dramatically over the past several decades. Preventive medicine has expanded well beyond treating disease to identifying health risks before they become serious problems. Today, patients routinely discuss blood pressure, cholesterol,...
Life science news 27 July 2026: GSK wins its first lung cancer approval with a selective ROS1 inhibitor, Lilly's triple agonist retatrutide delivers up to 22.6 per cent weight loss in two pivotal trials, and the MHRA clears what it calls the world's first lower-carbon...
Life science news 20 July 2026: the FDA approves the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly makes the largest psychedelics deal in Big Pharma history, and a first-in-class breast cancer therapy wins regulatory clearance in a landmark week for...
The first half of 2026 delivered one of the most consequential periods in recent biopharma history, reshaping competitive landscapes through record dealmaking, landmark regulatory approvals, and pivotal clinical breakthroughs. This biopharma H1 2026 review examines...
Editor’s note: This article reflects our plans and pricing as at July 2026. For current publishing options, see our Join and Publish page. Life Science Daily News launched in November 2025 with a simple premise: that researchers, biotech founders, healthcare...
The impact of climate change is usually discussed in terms of heatwaves and floods. While less visible, its impact on infectious diseases is equally consequential for public health. New data from the UK Health Security Agency (UKHSA) showing a surge in chikungunya...
A New Era for EHR Data A new study published in the latest issue of the Royal College of Physicians’ Future Healthcare Journal introduces PICTURE, an innovative data platform designed to convert routine electronic health record (EHR) data into actionable clinical...
After the success of previous summits, the revolutionary Smart Ageing Summit has announced a return to Oxford this May to host its fourth annual event. Rhodes House, University of Oxford is the perfect setting for non-profit organisation Oxford Health Project to host...
British research expertise to deliver faster cancer diagnosis and cleaner energy Major new backing for medical imaging centres across the UK alongside tidal energy testing expansion in Orkney and cutting-edge materials. From: Department for Science, Innovation and...
The global market for GLP-1 receptor agonists, once defined by scarcity and premium pricing, is entering a new phase. Prices for these blockbuster medicines, used to treat obesity and type 2 diabetes, are beginning to fall rapidly, forcing pharmaceutical companies,...
A Diagnostic Separation That Shaped a Generation For most of the modern history of psychiatry, autism and ADHD were treated as mutually exclusive conditions. Clinicians were trained to look for one or the other. Until the publication of DSM-5 in 2013, a dual diagnosis...
Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and...
Thousands of people living with schizophrenia and severe depression are being recruited by the NHS for a major new study which could unlock a “new era” of personalised treatment for severe mental illness. As part of the world’s largest mental health study, researchers...
THX Pharma (formerly known as Theranexus) has entered into a strategic licensing agreement with French pharmaceutical company Biocodex covering two experimental programs, Batten-1 and TX01, in a move aimed at accelerating development and expanding commercial reach....
Auxilium and Massachusetts Biomedical Initiatives (MBI) have announced a joint life sciences accelerator cohort in Worcester designed to attract and support founders developing the next generation of healthcare and life sciences technologies. Founders selected for the...
Cholesterol-lowering drugs known as statins, taken by millions worldwide, are significantly safer than often perceived, according to a major new scientific analysis. Conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration and published in The Lancet, the...
Eli Lilly and Company has officially selected Fogelsville, Pennsylvania, as the site for its newest $3.5 billion injectable medicine and device manufacturing facility. Operating under the name "Lilly Lehigh Valley," the project represents the final piece of a quartet...
AstraZeneca has announced plans to invest up to 15 billion US dollars to expand its research, development, and manufacturing operations in China, reinforcing the country’s role as a central pillar of the company’s global strategy. The long-term investment will fund...